BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Orlando R, Foggia M, Maraolo AE, Mascolo S, Palmiero G, Tambaro O, Tosone G. Prevention of hepatitis B virus infection: from the past to the future. Eur J Clin Microbiol Infect Dis. 2015;34:1059-1070. [PMID: 25678010 DOI: 10.1007/s10096-015-2341-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Liang Z, Huang Y, Li H, Zhang X, Shi K, Zang N, Wang M, Liang T, Wei W. Synthesis and evaluation of 3-phenylisoxazoline derivatives as non-nucleoside hepatitis B virus inhibitors. Tetrahedron 2022. [DOI: 10.1016/j.tet.2022.133177] [Reference Citation Analysis]
2 Wirsching S, Machtakova M, Borgans F, Pretsch L, Fichter M, Cacicedo ML, Thérien-Aubin H, Landfester K, Gehring S. OVA-PEG-R848 nanocapsules stimulate neonatal conventional and plasmacytoid dendritic cells. Front Pediatr 2022;10:966113. [PMID: 36177449 DOI: 10.3389/fped.2022.966113] [Reference Citation Analysis]
3 Meyer CU, Zepp F. Principles in Immunology for the Design and Development of Vaccines. Vaccine Design 2022. [DOI: 10.1007/978-1-0716-1884-4_2] [Reference Citation Analysis]
4 Liu YC, Hsu CM, Hsiao SY, Hsiao HH. Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. J Pers Med 2021;11:1108. [PMID: 34834460 DOI: 10.3390/jpm11111108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Gharbharan A, Jordans CCE, GeurtsvanKessel C, den Hollander JG, Karim F, Mollema FPN, Stalenhoef-Schukken JE, Dofferhoff A, Ludwig I, Koster A, Hassing RJ, Bos JC, van Pottelberge GR, Vlasveld IN, Ammerlaan HSM, van Leeuwen-Segarceanu EM, Miedema J, van der Eerden M, Schrama TJ, Papageorgiou G, Te Boekhorst P, Swaneveld FH, Mueller YM, Schreurs MWJ, van Kampen JJA, Rockx B, Okba NMA, Katsikis PD, Koopmans MPG, Haagmans BL, Rokx C, Rijnders BJA. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection. Nat Commun 2021;12:3189. [PMID: 34045486 DOI: 10.1038/s41467-021-23469-2] [Cited by in Crossref: 85] [Cited by in F6Publishing: 93] [Article Influence: 42.5] [Reference Citation Analysis]
6 Maraolo AE. Choosing the appropriate pharmacotherapy for hepatitis B during pregnancy: what are the considerations? Expert Opin Pharmacother 2021;22:1083-6. [PMID: 33797300 DOI: 10.1080/14656566.2021.1909571] [Reference Citation Analysis]
7 Maraolo AE, Buonomo AR, Zappulo E, Scotto R, Pinchera B, Gentile I. Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of Fungi. RRCT 2019;14:129-35. [DOI: 10.2174/1574887114666181204102516] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Shen XX, Qiu FZ, Shen LP, Yan TF, Zhao MC, Qi JJ, Chen C, Zhao L, Wang L, Feng ZS, Ma XJ. A rapid and sensitive recombinase aided amplification assay to detect hepatitis B virus without DNA extraction. BMC Infect Dis 2019;19:229. [PMID: 30836947 DOI: 10.1186/s12879-019-3814-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 12.0] [Reference Citation Analysis]
9 Pan T, Ding Y, Wu L, Liang L, He X, Li Q, Bai C, Zhang H. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors. European Journal of Medicinal Chemistry 2019;166:480-501. [DOI: 10.1016/j.ejmech.2019.01.059] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
10 Chang M. Prevention of Viral Hepatitis B and Related Complications. Viral Hepatitis in Children 2019. [DOI: 10.1007/978-981-13-0050-9_9] [Reference Citation Analysis]
11 Hong Y, Mao D, Wu R, Gao Z, Meng T, Wang R, Liu L, Miao J. Hepatitis B virus S gene therapy with 10-23 DNAzyme delivered by chitosan- g -stearic acid micelles. RSC Adv 2019;9:15196-204. [DOI: 10.1039/c9ra00330d] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
12 Momin B, Millman AJ, Nielsen DB, Revels M, Steele CB. Promising practices for the prevention of liver cancer: a review of the literature and cancer plan activities in the National Comprehensive Cancer Control Program. Cancer Causes Control 2018;29:1265-75. [PMID: 30506129 DOI: 10.1007/s10552-018-1094-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
13 Maraolo AE, Gentile I, Buonomo AR, Pinchera B, Borgia G. Current evidence on the management of hepatitis B in pregnancy. World J Hepatol 2018;10:585-94. [PMID: 30310536 DOI: 10.4254/wjh.v10.i9.585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
14 Blanco RY, Loureiro CL, Villalba JA, Sulbarán YF, Maes M, de Waard JH, Rangel HR, Jaspe RC, Pujol FH. Decreasing prevalence of Hepatitis B and absence of Hepatitis C Virus infection in the Warao indigenous population of Venezuela. PLoS One 2018;13:e0197662. [PMID: 29799873 DOI: 10.1371/journal.pone.0197662] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
15 Miller-handley H, Paulsen G, Hooper DK, Lake M, Lazear D, Danziger-isakov L. Durability of the hepatitis B vaccination in pediatric renal transplant recipients. Clin Transplant 2018;32:e13247. [DOI: 10.1111/ctr.13247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
16 Stanley M. Tumour virus vaccines: hepatitis B virus and human papillomavirus. Philos Trans R Soc Lond B Biol Sci 2017;372:20160268. [PMID: 28893935 DOI: 10.1098/rstb.2016.0268] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
17 Fiore M, Leone S, Maraolo AE, Berti E, Damiani G. Liver Illness and Psoriatic Patients. Biomed Res Int 2018;2018:3140983. [PMID: 29546055 DOI: 10.1155/2018/3140983] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
18 Yang A, Guo Z, Ren Q, Wu L, Ma Y, Hu A, Wang D, Ye H, Zhu X, Ju W, He X. Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study. PLoS One 2017;12:e0188190. [PMID: 29145470 DOI: 10.1371/journal.pone.0188190] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
19 Du Y, Chi X, Wang C, Jiang J, Kong F, Yan H, Wang X, Li J, Wu NC, Dai L, Zhang TH, Shu S, Zhou J, Yoshizawa JM, Li X, Bhattacharya D, Wu TT, Niu J, Sun R. Quantifying perinatal transmission of Hepatitis B viral quasispecies by tag linkage deep sequencing. Sci Rep 2017;7:10168. [PMID: 28860476 DOI: 10.1038/s41598-017-10591-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
20 Patel DP, Treat JR, Castelo-Socio L. Decreased Hepatitis B vaccine response in pediatric patients with atopic dermatitis, psoriasis, and morphea. Vaccine 2017;35:4499-500. [PMID: 28736199 DOI: 10.1016/j.vaccine.2017.07.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Choudhuri G, Ojha R, Negi TS, Gupta V, Saxena S, Choudhuri A, Pal S, Choudhuri J, Sangam A. A school-based intervention of screening a movie to increase hepatitis B vaccination levels among students in Uttar Pradesh, India: impact on knowledge, awareness, attitudes and vaccination levels. Hepatol Med Policy 2017;2:10. [PMID: 30288323 DOI: 10.1186/s41124-017-0027-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Gehring S, Pietrzak-nguyen A, Fichter M, Landfester K. Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B? Nanomedicine 2017;12:1205-7. [DOI: 10.2217/nnm-2016-0064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Borgia G, Maraolo AE, Gentile I. Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet. Infect Dis (Lond). 2017;49:584-587. [PMID: 28316268 DOI: 10.1080/23744235.2017.1303746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Narciso-Schiavon JL, Schiavon LL. To screen or not to screen? Celiac antibodies in liver diseases. World J Gastroenterol 2017; 23(5): 776-791 [PMID: 28223722 DOI: 10.3748/wjg.v23.i5.776] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
25 Qiu J, Xu B, Gong Q, Pan W, Liu C, Huang Z, Gu X, Liang G. Synthesis and Biological Evaluation of Matijin-Su Derivatives as Potential Antihepatitis B Virus and Anticancer Agents. Chem Biodivers 2016;13:1584-92. [PMID: 27451105 DOI: 10.1002/cbdv.201600113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
26 Kim J, Wu J. Molecular Models for Hepatitis B Virus Capsid Formation, Maturation, and Envelopment. Self-Assembling Systems 2016. [DOI: 10.1002/9781119113171.ch6] [Reference Citation Analysis]
27 Qiu Z, Lin X, Zhou M, Liu Y, Zhu W, Chen W, Zhang W, Guo L, Liu H, Wu G, Huang M, Jiang M, Xu Z, Zhou Z, Qin N, Ren S, Qiu H, Zhong S, Zhang Y, Zhang Y, Wu X, Shi L, Shen F, Mao Y, Zhou X, Yang W, Wu JZ, Yang G, Mayweg AV, Shen HC, Tang G. Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors. J Med Chem 2016;59:7651-66. [PMID: 27458651 DOI: 10.1021/acs.jmedchem.6b00879] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
28 Pietrzak-Nguyen A, Piradashvili K, Fichter M, Pretsch L, Zepp F, Wurm FR, Landfester K, Gehring S. MPLA-coated hepatitis B virus surface antigen (HBsAg) nanocapsules induce vigorous T cell responses in cord blood derived human T cells. Nanomedicine 2016;12:2383-94. [PMID: 27516081 DOI: 10.1016/j.nano.2016.07.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
29 Leng XJ, Yan XB. Status and development of anti-HBV drugs based on "HBF drug watch". Shijie Huaren Xiaohua Zazhi 2016; 24(15): 2336-2346 [DOI: 10.11569/wcjd.v24.i15.2336] [Reference Citation Analysis]